Neurogenetics of dystonia and paroxysmal dyskinesias

Neurogenetics: Scientific and Clinical Advances

Volumn , Issue , 2005, Pages 403-426

  Friedman, Jennifer ^a   Standaert, David G ^b  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927076495     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (146)

1. Jankovic J, Fahn S. DystonicDisorders. In: Jankovic J, TolosaE, eds. Parkinson’s Disease and Movement Disorders. Baltimore: Williams and Wilkins, 1993: 337-374.
2. Marsden CD. Investigation of dystonia. Adv Neurol 1988; 50:35-44.
3. Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol 1998; 78:1-10.
4. Bressman SB, DeLeonD, RaymondD, Ozelius LJ, BreakefieldXO, NygaardTG, Almasy L, Risch NJ, Kramer PL. Clinical-genetic spectrum of primary dystonia. Adv Neurol 1998; 78:79-92.
5. Fahn S. Concept and classification of dystonia. Adv Neurol 1988; 50:1-8.
6. Marsden CD, Harrison MJ. Idiopathic torsion dystonia (dystonia musculorum deformans). A review of forty-two patients. Brain 1974; 97:793-810.
7. Marsden CD. Dystonia: the spectrum of the disease. Res Publ Assoc Res Nerv Ment Dis 1976; 55:351-367.
8. Bressman SB. Dystonia genotypes, phenotypes, and classification. Adv Neurol 2004; 94:101-107.
9. Bressman SB, De Leon D, Brin MF, Risch N, Burke RE, Greene PE, Shale H, Fahn S. Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance. Ann Neurol 1989; 26:612-620.
10. Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988; 3:188-194.
11. Muller U, Steinberger D, Nemeth AH. Clinical and molecular genetics of primary dystonias. Neurogenetics 1998; 1:165-177.
12. Klein C, Breakefield XO, Ozelius LJ. Genetics of primary dystonia. Semin Neurol 1999; 19:271-280.
13. Marsden CD. Is tardive dyskinesia a unique disorder? Psychopharmacology Suppl 1985; 2:64-71.
14. Calne DB, Lang AE. Secondary dystonia. Adv Neurol 1988; 50:9-33.
15. Augood SJ, MartinDM, Ozelius LJ, BreakefieldXO, Penney JBJr, StandaertDG. Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain. Ann Neurol 1999; 46:761-769.
16. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends in Neurosciences 1989; 12:366-375.
17. Obeso JA, Rodriguez MC, DeLong MR. Basal ganglia pathophysiology. A critical review. Adv Neurol 1997; 74:3-18.
18. Parent A, Cicchetti F. The current model of basal ganglia organization under scrutiny. Mov Disord 1998; 13:199-202.
19. Vitek JL, Giroux M. Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia. Ann Neurol 2000; 47:S131-140.
20. Vitek JL, Chockkan V, Zhang JY, Kaneoke Y, Evatt M, DeLong MR, Triche S, Mewes K, Hashimoto T, Bakay RA. Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann Neurol 1999; 46: 22-35.
21. Chase TN, Tamminga CA, Burrows H. Positron emission tomographic studies of regional cerebral glucose metabolism in idiopathic dystonia. Adv Neurol 1988; 50:237-241.
22. Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Przedborski S, Fahn S. The metabolic topography of idiopathic torsion dystonia. Brain 1995; 118:1473-1484.
23. Eidelberg D, Moeller JR, Antonini A, Kazumata K, Nakamura T, Dhawan V, Spetsieris P, de Leon D, Bressman SB, Fahn S. Functional brain networks in DYT1 dystonia. Ann Neurol 1998; 44:303-312.
24. Lang A. Dopamine agonists and antagonists in the treatment of idiopathic dystonia. Adv Neurol 1988; 50:561-570.
25. Leenders KL, Quinn N, Frackowiak RS, Marsden CD. Brain dopaminergic system studied in patients with dystonia using positron emission tomography. Adv Neurol 1988; 50:243-247.
26. Perlmutter JS, Stambuk MK, Markham J, Black KJ, McGee-Minnich L, Jankovik J, Moerlein SM. Decreased [18F]Spiperone binding in putamen in idiopathic local dystonia. J Neurosci 1997; 17:843-850.
27. Hallett M. The Neurophysiology of dystonia. Arch Neurol 1998; 55:601-603.
28. Ikoma K, Samii A, Mercuri B, Wassermann EM, Hallett M. Abnormal cortical motor excitability in dystonia. Neurology 1996; 46:1371-1376.
29. Byl NN. Focal hand dystonia may result from aberrant neuroplasticity. Adv Neurol 2004; 94:19-28.
30. Hallett M. Dystonia: abnormal movements result from loss of inhibition. Adv Neurol 2004; 94:1-9.
31. Garraux G, Bauer A, Hanakawa T, Wu T, Kansaku K, Hallett M. Changes in brain anatomy in focal hand dystonia. Ann Neurol 2004; 55:736-739.
32. Bressman SB, De Leon D, Kramer PL, Ozelius LJ, Brin MF, Greene PE, Fahn S, Breakefield XO, Risch NJ. Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation. Ann Neurol 1994; 36:771-777.
33. Kramer PL, Heiman GA, et al. The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews. Am J Hum Genet 1994; 55:468-475.
34. Ozelius LJ, Kramer PL, et al. Strong allelic association between the torsion dystonia gene (DYT1) and loci on chromosome 9q34 in Ashkenazi Jews. Am J Hum Genet 1992; 50:619-628.
35. Ozelius LJ, Hewett JW, Page CE, Bressman SB, Kramer PL, Shalish C, De Leon D, Brin MF, Raymond D, Corey DP, Fahn S, Risch NJ, Buckler AJ, Gusella JF, Breakefield XO. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997; 17:40-48.
36. Warner TT, Fletcher NA, Davis MB, Ahmad F, Conway D, Feve A, Rondot P, Marsden CD, Harding AE. Linkage analysis in British and French families with idiopathic torsion dystonia. Brain 1993; 116:739-744.
37. Risch NJ, Bressman SB, De Leon D, Brin MF, Burke RE, Greene PE, Shale H, Claus EB, Cupples LA, Fahn S. Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. Am J Hum Genet 1990; 46:533-538.
38. Bressman SB, Hunt AL, et al. Exclusion of the DYT1 locus in a non-Jewish family with early-onset dystonia. Mov Disord 1994; 9:626-632.
39. Bressman SB, Sabatti C, Raymond D, De Leon D, Klein C, Kramer PL, Brin MF, Fahn S, Breakefield X, Ozelius LJ, Risch NJ. The DYT1 phenotype and guidelines for diagnostic testing. Neurology 2000; 54:1746-1752.
40. Valente EM, Warner TT, Jarman PR, Mathen D, Fletcher NA, Marsden CD, Bhatia KP, Wood NW. The role of DYT1 in primary torsion dystonia in Europe. Brain 1998; 121:2335-2339.
41. Opal P, Tintner R, Jankovic J, Leung J, Breakefield XO, Friedman J, Ozelius L. Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov Disord 2002; 17: 339-345.
42. Kabakci K, Hedrich K, Leung JC, Mitterer M, Vieregge P, Lencer R, Hagenah J, Garrels J, Witt K, Klostermann F, SvetelM, Friedman J, Kostic V, Bressman SB, Breakefield XO, Ozelius LJ, Pramstaller PP, Klein C. Mutations in DYT1: extension of the phenotypic and mutational spectrum. Neurology 2004; 62: 395-400.
43. Leung JC, Klein C, Friedman J, Vieregge P, Jacobs H, Doheny D, Kamm C, De Leon D, Pramstaller PP, Penney JB, Eisengart M, Jankovic J, Gasser T, Bressman SB, Corey DP, Kramer P, Brin MF, Ozelius LJ, Breakefield XO. Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics 2001; 3:133-143.
44. Ozelius LJ, Hewett JW, Page CE, Bressman SB, Kramer PL, Shalish C, De Leon D, Brin MF, Raymond D, Corey DP, Fahn S, Risch NJ, Buckler AJ, Gusella JF, Breakefield XO. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997; 17:40-48.
45. Breakefield XO, Kamm C, Hanson PI. TorsinA: movement at many levels. Neuron 2001; 31:9-12.
46. Neuwald AF, Aravind L, Spouge JL, Koonin EV. AAA+:A class of chaperonelikeATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res 1999; 9:27-43.
47. Hewett J, Gonzalez-Agosti C, Slater D, Ziefer P, Li S, Bergeron D, Jacoby DJ, Ozelius LJ, Ramesh V, Breakefield XO. Mutant torsinA, responsible for earlyonset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet 2000; 9:1403-1413.
48. Kustedjo K, Bracey MH, Cravatt BF. TorsinA and its torsion dystoniaassociated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations. J Biol Chem 2000; 275:27933-27939.
49. Kamm C, Boston H, Hewett J, Wilbur J, Corey DP, Hanson PI, Ramesh V, Breakefield XO. The early onset dystonia protein torsinA interacts with kinesin light chain 1. J Biol Chem 2004; 279:19882-19892.
50. Gonzalez-Alegre P, Paulson HL. Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia. J Neurosci 2004; 24:2593-2601.
51. Hewett J, Ziefer P, Bergeron D, Naismith T, Boston H, Slater D, Wilbur J Schuback D, Kamm C, Smith N, Camp S, Ozelius LJ, Ramesh V, Hanson PI, Breakefield XO. TorsinAin PC12 cells: localization in the endoplasmic reticulum and response to stress. J Neurosci Res 2003; 72:158-168.
52. Bragg DC, Camp SM, Kaufman CA, Wilbur JD, Boston H, Schuback DE, Hanson PI, Sena-Esteves M, Breakefield XO. Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors. Neuroscience 2004; 125:651-661.
53. Goodchild RE, Dauer WT. Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc Natl Acad Sci USA 2004; 101:847-852 (Epub 2004 Jan 7).
54. Rostasy K, Augood SJ, Hewett JW, Leung JC, Sasaki H, Ozelius LJ, Ramesh V, Standaert DG, Breakefield XO, Hedreen JC. TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol Dis 2003; 12:11-24.
55. Augood SJ, Hollingsworth Z, Albers DS, Yang L, Leung JC, Muller B, Klein C, Breakefield XO, Standaert DG. Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology 2002; 59:445-448.
56. Olanow C, McNaught K. Neuropathology in DYT1/torsinA-linked dystonia. Mov Disord 2004; 19(suppl 9):S112.
57. Carbon M, Trost M, Ghilardi MF, Eidelberg D. Abnormal brain networks in primary torsion dystonia. Adv Neurol 2004; 94:155-161.
58. Trost M, Carbon M, Edwards C, Ma Y, Raymond D, Mentis MJ, Moeller JR, Bressman SB, Eidelberg D. Primary dystonia: is abnormal functional brain architecture linked to genotype? Ann Neurol 2002; 52:853-856
59. Almasy L, Bressman SB, Raymond D, Kramer PL, Greene PE, Heiman GA, Ford B, Yount J, de Leon D, Chouinard S, Saunders-Pullman R, Brin MF, Kapoor RP, Jones AC, Shen H, Fahn S, Risch NJ, Nygaard TG. Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Ann Neurol 1997; 42:670-673.
60. Ozelius LJ. Update on the genetics of primary torsion dystonia loci DYT6, DYT7, and DYT13 and the dystonia-plus locus DYT12. Adv Neurol 2004; 94:109-112.
61. Waddy HM, Fletcher NA, Harding AE, Marsden CD. A genetic study of idiopathic focal dystonias. Ann Neurol 1991; 29:320-324.
62. Leube B, Rudnicki D, Ratzlaff T, Kessler KR, Benecke R, Auburger G. Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum Mol Genet 1996; 5:1673-1677.
63. Leube B, Hendgen T, Kessler KR, Knapp M, Benecke R, Auburger G. Sporadic focal dystonia in northwest Germany: molecular basis on chromosome 18p. Ann Neurol 1997; 42:111-114.
64. Leube B, Hendgen T, Kessler KR, Knapp M, Benecke R, Auburger G. Evidence for DYT7 being a common cause of cervical dystonia (torticollis) in Central Europe. Am J Med Genet 1997; 74:529-532.
65. Klein C, Ozelius LJ, Hagenah J, Breakefield XO, Risch NJ, Vieregge P. Search for a founder mutation in idiopathic focal dystonia from Northern Germany. Am J Hum Genet 1998; 63:1777-1782.
66. Leube B, Auburger G. Questionable role of adult-onset focal dystonia among sporadic dystonia patients. Ann Neurol 1998; 44:984-985.
67. Munchau A, Valente EM, Davis MB, Stinton V, Wood NW, Quinn NP, Bhatia KP. A Yorkshire family with adult-onset cranio-cervical primary torsion dystonia. Mov Disord 2000; 15:954-959.
68. Bentivoglio AR, Del Grosso N, Albanese A, Cassetta E, Tonali P, Frontali M. Non-DYT1 dystonia in a large Italian family. J Neurol Neurosurg Psychiatry 1997; 62:357-360.
69. Valente EM, Bentivoglio AR, Cassetta E, Dixon PH, Davis MB, Ferraris A, Ialongo T, Frontali M, Wood NW, Albanese A. Identification of a novel primary torsion dystonia locus (DYT13) on chromosome 1 p36 in an Italian family with cranial-cervical or upper limb onset. Neurol Sci 2001; 22:95-96.
70. Nygaard TG. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol 1993; 60:577-585.
71. Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 2003; 54(suppl 6):S32-45.
72. Segawa M, Nomura Y. Hereditary progressive dystonia with marked diurnal fluctuation. In: Segawa M, ed. Hereditary Progressive Dystonia With Marked Diurnal Fluctuation. New York, NY: Parthenon Publishing, 1993; 3:3-19.
73. Steinberger D, Weber Y, Korinthenberg R, Deuschl G, Benecke R, Martinius J, Muller U. High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with dopa-responsive dystonia. Ann Neurol 1998; 43:634-639.
74. Robinson R, McCarthy GT, Bandmann O, Dobbie M, Surtees R, Wood NW. GTP cyclohydrolase deficiency; intrafamilial variation in clinical phenotype, including levodopa responsiveness. J Neurol Neurosurg Psychiatry 1999; 66: 86-89.
75. Bandmann O, Daniel S, Marsden CD, Wood NW, Harding AE. The GTPcyclohydrolase I gene in atypical parkinsonian patients: a clinico-genetic study. J Neurol Sci 1996; 141:27-32.
76. Bandmann O, Nygaard TG, Surtees R, Marsden CD, Wood NW, Harding AE. Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 1996; 5:403-406.
77. Bandmann O, Valente EM, Holmans P, Surtees RA, Walters JH, Wevers RA, Marsden CD, Wood NW. Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 1998; 44:649-656.
78. Bandmann O, Marsden CD, Wood NW. Atypical presentations of doparesponsive dystonia. Adv Neurol 1998; 78:283-290.
79. Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976; 14:215-233.
80. Furukawa Y, Lang AE, Trugman JM, Bird TD, Hunter A, Sadeh M, Tagawa T, St George-Hyslop PH, Guttman M, Morris LW, Hornykiewicz O, Shimadzu M, Kish SJ. Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology 1998; 50: 1015-1020.
81. Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 1991; 41:174-181.
82. Furukawa Y, Kish SJ. Dopa-responsive dystonia: recent advance’s and remaining issues to be addressed. Mov Disord 1999; 14:709-715.
83. Ichinose H, Ohye T, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994; 8:236-242.
84. Jeon BS, Jeong JM, Park SS, Lee MC. Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopamine deficiency. Adv Neurol 1998; 78:309-317.
85. Hyland K, Arnold LA, Trugman JM. Defects of biopterin metabolism and biogenic amine biosynthesis: clinical diagnostic, and therapeutic aspects. Adv Neurol 1998; 78:301-308.
86. Bonafe L, Thony B, Leimbacher W, Kierat L, Blau N. Diagnosis of doparesponsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts. Clin Chem 2001; 47:477-485.
87. Hwu WL, Wang PJ, Hsiao KJ, Wang TR, Chiou YW, Lee YM. Doparesponsive dystonia induced by a recessive GTP cyclohydrolase I mutation. Hum Genet 1999; 105:226-230.
88. Grotzsch H, Pizzolato GP, Ghika J, Schorderet D, Vingerhoets FJ, Landis T, Burkhard PR. Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14. Neurology 2002; 58:1839-1842.
89. Bartholome K, Ludecke B. Mutations in the tyrosine hydroxylase gene cause various forms of L-dopa-responsive dystonia. Adv Pharmacol 1998; 42:48-49.
90. Ludecke B, Dworniczak B, Bartholome K. A point mutation in the tyrosine hydroxylase gene associated with Segawa’s syndrome. Hum Genet 1995; 95:123-125.
91. Ludecke B, Knappskog PM, Clayton PT, Surtees RA, Clelland JD, Heales SJ, BrandMP, BartholomeK, FlatmarkT.Recessively inheritedL-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Genet 1996; 5:1023-1028.
92. Brautigam C, Wevers RA, Jansen RJ, Smeitink JA, de Rijk-van Andel JF, Gabreels FJ, Hoffmann GF. Biochemical hallmarks of tyrosine hydroxylase deficiency. Clin Chem 1998; 44:1897-1904.
93. van den Heuvel LP, Luiten B, Smeitink JA, de Rijk-van Andel JF, Hyland K, Steenbergen-Spanjers GC, Janssen RJ, Wevers RA. A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population. Hum Genet 1998; 102:644-646.
94. AbelingNG, vanGennipAH, BarthPG, vanCruchtenA, WestraM, WijburgFA. Aromatic L-amino acid decarboxylase deficiency: a new case with a mild clinical presentation and unexpected laboratory findings. J Inherit Metab Dis 1998; 21: 240-242.
95. Hyland K, Clayton PT. Aromatic amino acid decarboxylase deficiency in twins. J Inherit Metab Dis 1990; 13:301-304.
96. Hyland K, Surtees RA, Rodeck C, Clayton PT. Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. Neurology 1992; 42:1980-1988.
97. Korenke GC, Christen HJ, Hyland K, Hunneman DH, Hanefeld F. Aromatic L-amino acid decarboxylase deficiency: an extrapyramidal movement disorder with oculogyric crises. Eur J Paediatr Neurol 1997; 1:67-71.
98. Maller A, Hyland K, Milstien S, Biaggioni I, Butler IJ. Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a second family. J Child Neurol 1997; 12:349-354.
99. Swoboda KJ, Hyland K, Goldstein DS, Kuban KC, Arnold LA, Holmes CS, Levy HL. Clinical and therapeutic observations in aromatic L-amino acid decarboxylase deficiency. Neurology 1999; 53:1205-1211.
100. Swoboda KJ, Saul JP, McKenna CE, Speller NB, Hyland K. Aromatic L-amino acid decarboxylase deficiency: overview of clinical features and outcomes. Ann Neurol 2003; 54(suppl 6):S49-55.
101. Hanihara T, Inoue K, Kawanishi C, Sugiyama N, Miyakawa T, Onishi H, Yamada Y, Osaka H, Kosaka K, Iwabuchi K, Owada M. 6-Pyruvoyltetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study. Mov Disord 1997; 12: 408-411.
102. Nomura Y, Uetake K, Yukishita S, Hagiwara H, Tanaka T, Tanaka R, Hachimori K, Nishiyama N, Segawa M. Dystonias responding to levodopa and failure in biopterin metabolism. Adv Neurol 1998; 78:253-266.
103. Gasser T. Inherited myoclonus-dystonia syndrome. Adv Neurol 1998; 78: 325-334.
104. Grabowski M, Zimprich A, Lorenz-Depiereux B, Kalscheuer V, Asmus F, Gasser T, Meitinger T, Strom TM. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet 2003; 11:138-144.
105. Quinn NP, Rothwell JC, Thompson PD, Marsden CD. Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion. Adv Neurol 1988; 50:391-401.
106. Quinn NP. Essential myoclonus and myoclonic dystonia. Mov Disord 1996; 11:119-124.
107. Klein C, Schilling K, Saunders-Pullman RJ, Garrels J, Breakefield XO, Brin MF, de Leon D, DohenyD, FahnS, Fink JS, Forsgren L, Friedman J, Frucht S, Harris J, Holmgren G, Kis B, Kurlan R, Kyllerman M, Lang AE, Leung J, Raymond D, Robishaw JD, Sanner G, Schwinger E, Tabamo RE, Tagliati M. A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am J Hum Genet 2000; 67:1314-1319.
108. Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M, Scheidtmann K, Kern P, Winkelmann J, Muller-Myhsok B, Riedel L, Bauer M, Muller T, Castro M, Meitinger T, Strom TM, Gasser T. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001; 29:66-69.
109. Lim LE, Campbell KP. The sarcoglycan complex in limb-girdle muscular dystrophy. Curr Opin Neurol 1998; 11:443-452.
110. Asmus F, Gasser T. Inherited myoclonus-dystonia. Adv Neurol 2004; 94: 113-119.
111. Schule B, Kock N, Svetel M, Dragasevic N, Hedrich K, De Carvalho Aguiar P, Liu L, Kabakci K, Garrels J, Meyer EM, Berisavac I, Schwinger E, Kramer PL, Ozelius LJ, Klein C, Kostic V. Genetic heterogeneity in ten families with myoclonus-dystonia. J Neurol Neurosurg Psychiatry 2004; 75:1181-1185.
112. Valente EM, Misbahuddin A, Brancati F, Placzek MR, Garavaglia B, Salvi S, Nemeth A, Shaw-Smith C, Nardocci N, Bentivoglio AR, Berardelli A, Eleopra R, Dallapiccola B, Warner TT. Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov Disord 2003; 18:1047-1051.
113. Klein C, Brin MF, Kramer P, Sena-Esteves M, de Leon D, Doheny D, Bressman S, Fahn S, Breakefield XO, Ozelius LJ. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proc Natl Acad Sci USA 1999; 96:5173-5176.
114. DA, Bulman D, George-Hyslop PS, Lang AE. Inherited myoclonus-dystonia: evidence supporting genetic heterogeneity. Mov Disord 2001; 16:106-110.
115. Grimes DA, Han F, Lang AE, St George-Hyssop P, Racacho L, Bulman DE. A novel locus for inherited myoclonus-dystonia on 18p11. Neurology 2002; 59:1183-1186.
116. Dobyns WB, Ozelius LJ, Kramer PL, Brashear A, Farlow MR, Perry TR, Walsh LE, Kasarskis EJ, Butler IJ, Breakefield XO. Rapid-onset dystoniaparkinsonism. Neurology 1993; 43:2596-2602.
117. Brashear A, Butler IJ, Hyland K, Farlow MR, Dobyns WB. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism. Ann Neurol 1998; 43:521-526.
118. Pittock SJ, Joyce C, O’Keane V, Hugle B, Hardiman MO, Brett F, Green AJ, Barton DE, King MD, Webb DW. Rapid-onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindred. Neurology 2000; 55:991-995.
119. Kamm C, Leung J, Joseph S, Dobyns WB, Brashear A, Breakefield XO, Ozelius LJ. Refined linkage to the RDP/DYT12 locus on 19q13.2 and evaluation of GRIK5 as a candidate gene. Mov Disord 2004; 19:845-847.
120. De Carvalho Aguiar P, Sweadner KJ, Penniston JT, Zaremba J, Liu L, Caton M, Linazasoro G, Borg M, Tijssen MA, Bressman SB, Dobyns WB, Brashear A, Ozelius LJ. Mutations in the Na(+)/K(+)-ATPase alpha3 Gene ATP1A3 Are Associated with Rapid-OnsetDystonia Parkinsonism. Neuron 2004; 43:169-175.
121. De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003; 33:192-196.
122. Vanmolkot KR, Kors EE, Hottenga JJ, TerwindtGM, Haan J, HoefnagelsWA, Black DF, Sandkuijl LA, Frants RR, Ferrari MD, van den Maagdenberg AM. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 2003; 54:360-366.
123. Fahn S. Paroxysmal Dyskinsias. In: Marsden CD, Fahn S, eds. Movement Disorders 3. Oxford: Butterworth-Heineman, 1994:310-345.
124. Bhatia KP. The paroxysmal dyskinesias. J Neurol 1999; 246:149-155.
125. PhillipsHA, Scheffer LE, Berkovic SF, Hollway GE, Sutherland GR, Mulley JC. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat Genet 1995; 10:117-118.
126. Mount L, Reback S. Familial paroxysmal choreoathetosis: preliminary report on an hitherto undescribed clinical syndrome. Archives of Neurology and Psychiatry 1940; 44:841-847.
127. DemirkiranM, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995; 38:571-579.
128. Fouad GT, Servidei S, Durcan S, Bertini E, Ptacek LJ. A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q. Am J Hum Genet 1996; 59:135-139.
129. Fink JK, Rainer S, Wilkowski J, Jones SM, Kume A, Hedera P, Albin R, Mathay J, Girbach L, Varvil T, Otterud B, Leppert M. Paroxysmal dystonic choreoathetosis: tight linkage to chromosome 2q. Am J Hum Genet 1996; 59:140-145.
130. Jarman PR, Davis MB, Hodgson SV, Marsden CD, Wood NW. Paroxysmal dystonic choreoathetosis. Genetic linkage studies in a British family. Brain 1997; 120:2125-2130.
131. Raskind WH, Bolin T, Wolff J, Fink J, Matsushita M, Lift M, Lipe H, Bird TD. Further localization of a gene for paroxysmal dystonic choreoathetosis to a 5-cM region on chromosome 2q34. Hum Genet 1998; 102:93-97.
132. Grunder S, Geisler HS, Rainier S, Fink JK. Acid-sensing ion channel (ASIC) 4 gene: physical mapping, genomic organisation, and evaluation as a candidate for paroxysmal dystonia. Eur J Hum Genet 2001; 9:672-676.
133. Auburger G, Ratzlaff T, et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 1996; 31:90-94.
134. Kertesz A. Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology 1967; 17:680-690.
135. Swoboda KJ, Soong BW, McKenna C, Brunt ER, Litt M, Bale JF, Jr., Ashizawa T, Bennett LB, Bowcock AM, Roach ES, Gerson D, Matsuura T, Heydemann PT, Nespeca MP, Jankovic J, Leppert M, Ptacek LJ. Paroxysmal kinesigenic dyskinesia and infantile convulsions. Clinical and linkage studies.2000. Neurology 2001; 57:S42-48.
136. Guerrini R, Bonanni P, Nardocci N, Parmeggiani L, Piccirilli M, De Fusco M, Aridon P, Ballabio A, Carrozzo R, Casari G. Autosomal recessive rolandic epilepsy with paroxysmal exercise-induced dystonia and writer’s cramp: delineation of the syndrome and gene mapping to chromosome 16p12-11.2. Ann Neurol 1999; 45:344-352.
137. Caraballo R, Pavek S, Lemainque A, Gastaldi M, Echenne B, Motte J, Genton P, Cersosimo R, Humbertclaude V, Fejerman N, Monaco AP, Lathrop MG, Rochette J, Szepetowski P. Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome. Am J Hum Genet 2001; 68:788-794.
138. Nemeth AH. The genetics of primary dystonias and related disorders. Brain 2002; 125:695-721.
139. Lotze T, Jankovic J. Paroxysmal kinesigenic dyskinesias. Semin Pediatr Neurol 2003; 10:68-79.
140. Defazio G, Berardelli A, Abbruzzese G, Lepore V, Coviello V, Acquistapace D, Capus L, Carella F, De Berardinis MT, Galardi G, Girlanda P, Maurri S, Albanese A, Bertolasi L, Liguori R, Rossi A, Santoro L, Tognoni G, Livrea P. Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group. J Neurol Neurosurg Psychiatry 1998; 64:25-32.
141. Fletcher NA, Harding AE, Marsden CD. A case-control study of idiopathic torsion dystonia. Mov Disord 1991; 6:304-309.
142. Factor SA. Cervical dystonia in twins. Mov Disord 2002; 17:846-847.
143. Wunderlich S, Reiners K, Gasser T, Naumann M. Cervical dystonia in monozygotic twins: case report and review of the literature. Mov Disord 2001; 16:714-718.
144. Misbahuddin A, Placzek MR, Warner TT. Focal dystonia is associated with a polymorphism of the dopamine D5 receptor gene. Adv Neurol 2004; 94: 143-146.
145. Placzek MR, Misbahuddin A, Chaudhuri KR, Wood NW, Bhatia KP, Warner TT. Cervical dystonia is associated with a polymorphism in the dopamine (D5) receptor gene. J Neurol Neurosurg Psychiatry 2001; 71:262-264.
146. Matsumoto S, Nishimura M, Sakamoto T, Asanuma K, Izumi Y, Shibasaki H, Kamatani N, Nakamura T, Kaji R. Modulation of the onset age in primary dystonia by APOE genotype. Neurology 2003; 60:2003-2005.